Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):504-6. doi: 10.1097/01.qai.0000167158.90722.73.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anemia / chemically induced
  • Anemia / drug therapy*
  • Antiviral Agents / adverse effects*
  • Drug Administration Schedule
  • Epoetin Alfa
  • Erythropoietin / therapeutic use*
  • Female
  • HIV Infections / complications
  • Hematinics / therapeutic use*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Interferons / adverse effects*
  • Male
  • Middle Aged
  • Quality of Life
  • Recombinant Proteins
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Hematinics
  • Recombinant Proteins
  • Erythropoietin
  • Ribavirin
  • Epoetin Alfa
  • Interferons